Zdrowie i gospodarka · 02/11/2017
FDA Renews Patient Engagement Advisory Committee for 2 Years
The FDA Commissioner has renewed the Patient Engagement Advisory Committee for an additional 2 years, extending its charter until October 6, 2019, in accordance with the public interest
Source: Federal Register — Food and Drug AdministrationOpen original release →